FDA delay

AZ
Favicon Fierce Biotech

FDA delays ruling on AstraZeneca drug after negative adcomm vote

The FDA deferred its ruling on AstraZeneca’s camizestrant to review analyses filed after an advisory committee voted against the breast cancer asset.
Nick Paul Taylor May 27, 2026 4:43am
clock calendar time late delayed alarm

The FDA blamed COVID for delaying its review of Amicus' drug

Oct 31, 2022 3:08pm